Lantern Pharma Inc. (LTRN) NASDAQ

3.34

-0.16(-4.57%)

Updated at December 24 01:00PM

Currency In USD

Valuation

Market Cap34.33M
Enterprise Value27.06M
P/E Ratio-1.87
PEG Ratio-0.57
Price/Sales Ratio371.13
Price/Book Ratio2.88
Enterprise/Revenue312.35
Enterprise/EBITDA-1.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-191.24
Operating Margin-203.69

Management Effectiveness

Return On Assets-1.1
Return On Equity-1

Income Statement

Revenue0
Revenue/Share0.01
Gross Profit0
EBITDA-22.2M
Net Income-20.78M
Diluted EPS-1,930.92

Balance Sheet

Total Cash12.36M
Total Cash/Share1.47
Total Debt93,954
Total Debt/Equity0.01
Current Ratio3.52
Book Value Per Share1.16

Price History

52-Week Change6.71
52-Week High6.12
52-Week Low2.55
Moving Average 50 Days3.66
Moving Average 200 Days3.77

Statistics

Average Volume114,080
Shares Outstanding11.18M
% Held by Institutions21.09

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A